The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma

NCT01813214 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Recruitment difficulties.

Conditions

Melanoma

Interventions

DRUG: Vemurafenib
DRUG: Cobimetinib

Sponsor

Georgetown University

Collaborators

[object Object]
[object Object]